Daniel Loeb’s hedge fund, Third Point, has taken a significant position in Kenvue Inc. (NYSE:KVUE), acquiring 8.9 million ...

Kenvue announced its global community engagement efforts in celebration of Kenvue Cares Week, the company’s signature annual ...

Kenvue Inc. (NYSE:KVUE) operates as a consumer health company in the U.S. and internationally. It operates through three ...

Kenvue, a Johnson & Johnson spinoff, offers long-term upside with solid dividends despite near-term economic headwinds. Read ...

The Johnson & Johnson spinoff that makes Tylenol and Benadryl, logged earnings growth ahead of expectations, named a new ...

Shares of Kenvue Inc. (NYSE: KVUE) traded 6% higher on Thursday morning after the company announced upbeat first-quarter ...

Kenvue (KVUE) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.28 per share a year ago. These figures are ...

Kenvue (KVUE) reported $3.74 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 3.9%. EPS of $0.24 for the same period compares to $0.28 a year ago. The ...

Shares of Kenvue Inc. KVUE rose 2.93% to $23.88 Thursday, on what proved to be an all-around great trading session for the ...

Kenvue on Thursday forecast that its annual profit would be flat year-over-year as the consumer health firm anticipates a ...

This was the stock's second consecutive day of losses.

This was the stock's third consecutive day of losses.